<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="196436-2018" EDITION="2018087"><TECHNICAL_SECTION><RECEPTION_ID>18-200059-001</RECEPTION_ID><DELETION_DATE>20180812</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>87</NO_OJ><DATE_PUB>20180505</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 087-196436</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:196436-2018:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL/><ORIGINAL_CPV CODE="33652100">Antineoplastic agents</ORIGINAL_CPV><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">305 250,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">305 250,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180504</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="1">Ministry or any other national or federal authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Мадрид</TI_TOWN><TI_TEXT>Антинеопластични средства</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Cytostatika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastische Mittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Μαδρίτη</TI_TOWN><TI_TEXT>Αντινεοπλασματικά φάρμακα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Agentes antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastilised ained</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Solunsalpaajat ja sytostaatit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antinéoplasiques</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Maidrid</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastični lijekovi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Daganatellenes szerek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Agenti antineoplastici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Madridas</TI_TOWN><TI_TEXT>Antinavikiniai vaistai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Madride</TI_TOWN><TI_TEXT>Antineoplastiskie līdzekļi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Aġenti ta' l-antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastische middelen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Madryt</TI_TOWN><TI_TEXT>Środki przeciwnowotworowe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplazice</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Antineoplastické činidlá</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Zdravila z delovanjem na novotvorbe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT>Cytostatika/cytotoxiska medel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Hospital Clínico San Carlos de Madrid</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="ES" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Hospital Clínico San Carlos de Madrid</OFFICIALNAME><NATIONALID>Q2877008i</NATIONALID></ORGANISATION><ADDRESS>C/ Profesor Martín Lagos, s/n</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28040</POSTAL_CODE><COUNTRY VALUE="ES"/><CONTACT_POINT>Servicio de Contratación Administrativa</CONTACT_POINT><PHONE>+34 913303000</PHONE><E_MAILS><E_MAIL>contratacionadva.hcsc@salud.madrid.org</E_MAIL></E_MAILS><FAX>+34 913303062</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_BUYER>http://www.madrid.org/contratospublicos</URL_BUYER></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="MINISTRY"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Suministro de medicamentos: MabThera 1400 mg solución para inyección subcutánea, vial de 15 ml (Rituximab) para el servicio de farmacia del Hospital Clínico San Carlos de Madrid</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION_W_PUB><SHORT_CONTRACT_DESCRIPTION><P>Suministro de medicamentos: MabThera 1400 mg solución para inyección subcutánea, vial de 15 ml (Rituximab).</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652100"/></CPV_MAIN></CPV></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="305250.00">305 250,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><F03_PT_NEGOTIATED_WITHOUT_COMPETITION><ANNEX_D><NO_MANUFACTURED_BY_DIRECTIVE/><JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASONS_PROVIDED_PARTICULAR_TENDERER><REASONS_PROVIDED_PARTICULAR_TENDERER_EXCLUSIVE_RIGHTS/></REASONS_PROVIDED_PARTICULAR_TENDERER><NO_EXTREME_URGENCY_EVENTS_UNFORESEEABLE/><NO_ADDITIONAL_WORKS/><NO_SUPPLIES_QUOTED_PURCHASED_COMMODITY_MARKET/></JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><NO_ONLY_IRREGULAR_INACCEPTABLE_TENDERERS/><REASON_CONTRACT_LAWFUL/></ANNEX_D></F03_PT_NEGOTIATED_WITHOUT_COMPETITION></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL_F03><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL_F03><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>PNSP 2018-1-008</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><NO_PREVIOUS_PUBLICATION_EXISTS_F3/></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>PNSP 2018-1-008</CONTRACT_NUMBER><CONTRACT_TITLE><P>Suministro de medicamentos: MabThera 1400 mg solución para inyección subcutánea, vial de 15 ml (Rituximab) para el servicio de farmacia del Hospital Clínico San Carlos de Madrid</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>19</DAY><MONTH>02</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Roche Farma, S. A.</OFFICIALNAME></ORGANISATION><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="346875.00">346 875,00</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="305250.00">305 250,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>1</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Tribunal Administrativo de Contratación Pública</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Carrera de San Jerónimo, 13, 1ª planta</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28014</POSTAL_CODE><COUNTRY VALUE="ES"/><E_MAILS><E_MAIL>tribunal.contratación@madrid.org</E_MAIL></E_MAILS><PHONE>+34 917206346/5</PHONE><FAX>+34 917206347</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>04</DAY><MONTH>05</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>